Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration

被引:139
作者
Spielman, Lindsay J. [1 ]
Little, Jonathan P. [2 ]
Klegeris, Andis [1 ]
机构
[1] Univ British Columbia, Dept Biol, Kelowna, BC V1V 1V7, Canada
[2] Univ British Columbia, Sch Hlth & Exercise Sci, Kelowna, BC V1V 1V7, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Adipose tissue; Cytokines; Neuroinflammation; Alzheimer's disease; Parkinson's disease; Huntington's disease; GROWTH-FACTOR-I; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; BODY-MASS INDEX; PROTEIN-KINASE B/AKT; BLOOD-BRAIN-BARRIER; HIGH-FAT DIET; NF-KAPPA-B; ALZHEIMERS-DISEASE; HUNTINGTONS-DISEASE;
D O I
10.1016/j.jneuroim.2014.06.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Obesity is a growing epidemic that contributes to several brain disorders including Alzheimer's, Parkinson's, and Huntington's diseases. Obesity could promote these diseases through several different mechanisms. Here we review evidence supporting the involvement of two recently recognized factors linking obesity with neurodegeneration: the induction of pro-inflammatory cytokines and onset of insulin and insulin-like growth factor 1 (IGF-1) resistance. Excess peripheral pro-inflammatory mediators, some of which can cross the blood brain barrier, may trigger neuroinflammation, which subsequently exacerbates neurodegeneration. Insulin and IGF-1 resistance leads to weakening of neuroprotective signaling by these molecules and can contribute to onset of neurodegenerative diseases. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:8 / 21
页数:14
相关论文
共 241 条
[1]   Midlife adiposity and the future risk of Parkinson's disease [J].
Abbott, RD ;
Ross, GW ;
White, LR ;
Nelson, JS ;
Masaki, KH ;
Tanner, CM ;
Curb, JD ;
Blanchette, PL ;
Popper, JS ;
Petrovitch, H .
NEUROLOGY, 2002, 59 (07) :1051-1057
[2]   Normal age-dependent values of serum insulin growth factor-I: Results from a healthy Italian population [J].
Aimaretti, G. ;
Boschetti, M. ;
Corneli, G. ;
Gasco, V. ;
Valle, D. ;
Borsotti, M. ;
Rossi, A. ;
Barreca, A. ;
Fazzuoli, L. ;
Ferone, D. ;
Ghigo, E. ;
Minuto, F. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2008, 31 (05) :445-449
[3]   Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity [J].
AL-Suhaimi, Ebtesam A. ;
Shehzad, Adeeb .
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2013, 18
[4]   Differential phosphorylation of IRS-1 by insulin and insulin-like growth factor I receptors in Chinese hamster ovary cells [J].
Amoui, M ;
Craddock, BP ;
Miller, WT .
JOURNAL OF ENDOCRINOLOGY, 2001, 171 (01) :153-162
[5]  
Andre C., 2014, BRAIN BEHAV IMMUN
[6]   Interferon-β treatment associated with a biochemical profile suggestive of acromegaly. A case report of a patient treated for multiple sclerosis [J].
Andreassen, Mikkel ;
Frystyk, Jan ;
Miller, Karen K. ;
Kristensen, Lars O. .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2010, 70 (07) :519-522
[7]   Huntington's disease of the endocrine pancreas: Insulin deficiency and diabetes mellitus due to impaired insulin gene expression [J].
Andreassen, OA ;
Dedeoglu, A ;
Stanojevic, V ;
Hughes, DB ;
Browne, SE ;
Leech, CA ;
Ferrante, RJ ;
Habener, JF ;
Beal, MF ;
Thomas, MK .
NEUROBIOLOGY OF DISEASE, 2002, 11 (03) :410-424
[8]  
[Anonymous], 2013, DEM PUBL HLTH PRIOR, DOI DOI 10.1007/S00406-005-0624-4
[9]   Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells [J].
Ariga, M ;
Nedachi, T ;
Akahori, M ;
Sakamoto, H ;
Ito, Y ;
Hakuno, F ;
Takahashi, S .
BIOCHEMICAL JOURNAL, 2000, 348 (02) :409-416
[10]   Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83